You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
14 November 2025 - Ionis Pharmaceuticals Inc (Nasdaq:IONS), a US-based provider of RNA-targeted medicines, and Japanese healthcare company Otsuka Pharmaceutical Co Ltd announced on Friday that the Committee for Medicinal Products for Human Use (CHMP)...
13 November 2025 - Chinese biotechnology company Ascletis Pharma Inc (HKEX:1672) announced on Wednesday the co-formulation of ASC36, a once-monthly next-generation amylin receptor agonist, and ASC35, a once-monthly next-generation GLP-1R/GIPR dual ag...
13 November 2025 - Taiwan-based contract development and manufacturing organisation EirGenix Inc (TWSE:6589) announced on Wednesday that it has signed a second global exclusive licensing agreement with Sandoz AG (SIX:SDZ) (OTCQX:SDZNY), a Swiss compa...
12 November 2025 - American clinical-stage biotechnology company Longeveron Inc. (NASDAQ: LGVN) announced on Wednesday that it has received a new United States patent for its proprietary mesenchymal stem cell treatment.The patent, issued by the Unite...
12 November 2025 - Biotechnology company Anixa Biosciences Inc (NASDAQ: ANIX) announced on Wednesday that the United States Patent and Trademark Office will issue U.S. Patent No. 12,472,205 on 18 November 2025, covering key aspects of the company...
12 November 2025 - Danish clinical-stage biotechnology company ExpreS2ion Biotechnologies ApS, an affiliate of ExpreS2ion Biotech Holding AB (STO: EXPRS2), announced on Wednesday that it has signed a definitive licensing agreement with vaccine manufa...
12 November 2025 - ABIONYX Pharma (Euronext Paris:ABNX), a biopharma company focused on breakthrough biotherapies to address life-threatening conditions with no effective treatments, announced on Wednesday that it is in advanced strategic discussions...